AH Realty Trust, Inc. (NYSE: AHRT) awarded director Theodore Bigman 2,317 shares at $6.47 per share on September 15, 2026. The transaction represented about 2.8% of Bigman’s resulting shareholding. The award lifts Bigman’s reported ownership to 82,317 shares. Transaction code A identifies the entry …
Credo Technology Group Holding Ltd (NASDAQ: CRDO) Chief Executive Officer Brennan William Joseph sold 16,672 shares at prices ranging from $150.39 to $153.39 per share. The transaction involved his personal holdings and was completed on 14 September 2026.
Brughera Marco Maria exercised options for 15,545 FENNEC PHARMACEUTICALS INC. (NASDAQ: FENC) shares at $2.11 per share, with the resulting record showing ownership of 15,545 shares. The transaction was dated 15 September 2026 and classified under SEC transaction code M.
Kirn David sold 58,333 shares of 4D Molecular Therapeutics at $13.90 per share. The transaction involved the company’s stock and reduced the reported position while leaving a substantial holding in place.
Krystal Biotech, Inc. (NASDAQ: KRYS) awarded director Gangolli Julian S a total of 1,658 derivative securities. The transactions were dated 14 September 2026 and carried a stated price of $0 per share, marking a change in the director’s reported derivative position. The award was …
Metabowlite, Inc. has a $500,000 exempt securities offering structured as a Simple Agreement for Future Equity. The transaction gives investors a defined financing instrument and a stated offering size. Biotechnology is the industry category identified for the transaction.
PUMA BIOTECHNOLOGY, INC. (NASDAQ: PBYI) director Wilson Troy Edward sold 5,000 shares at $9.10 per share. The transaction took place on Sept. 14, 2026, and represents about 8.4% of his prior shareholding.
Theia Imaging LLC has set a $1,000,000 target for an exempt securities offering, with $160,000 already sold. The securities are designated as SAFE, or Simple Agreement for Future Equity, giving investors a defined instrument type for the transaction.
TuHURA Biosciences, Inc. (NASDAQ: HURA) adopted a 2026 inducement equity incentive plan that reserves 5,000,000 shares of common stock for potential awards. The plan is intended to help attract new employees to TuHURA Biosciences or its subsidiaries through equity-based and cash incentives. Qualifying grants …
That earnings report revealed decelerating Gross Transaction Volume growth and a strategic pivot away from planned new-trades expansion to redirectInvestmenttoward the company's Max AI platform, a disclosure that triggered a roughly 30% single-day plunge and has since sparked an investigation by a law firm …